the overarching objective of this funding opportunity is to address the pressing needs of psp organizations and support service providers in providing effective and evidence-based supports for psp experiencing ptsi.

the specific objectives of this funding opportunity are:

• to contribute to the improved health of psp with ptsi by generating relevant and timely evidence around the merit, validity, and appropriateness of the two targeted support systems identified through this program.
• to assess the potential impacts of these two targeted support systems on psp, including through novel and innovative research approaches directly using the core technologies/methodologies in place at the research and coordination hubs.
• to contribute to the development of sustainable support systems for psp by catalyzing research on potentially effective support models, and through the development of evidence summaries, best practices, and guidance documents for the targeted support models identified through this program.

cihr’s hiv/aids and stbbi research initiative, with strategic leadership from the cihr institute of infection and immunity (iii), will provide funding to applicants requesting support to attend the 24th international aids conference (aids 2022). aids 2022, which is the largest gathering on hiv and aids in the world, is being organized by the international aids society (ias) and will take place from july 29-august 2, 2022 in montreal, canada. this award is intended to support individuals participating at the conference either in person or virtually.

the fy22 defense appropriations act is anticipated to provide funding for the arp to support research of exceptional scientific merit and innovation with high impact that focuses on autism spectrum disorders (asd).  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate, manages the defense health program’s research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the cdmrp at the u.s. army medical research and development command (usamrdc).

the fy22 arp funding opportunity announcements for the following award mechanisms will be posted on the grants.gov website. 

funding opportunities-fy22 autism research program, congressionally directed medical research programs (cdmrp) (army.mil)

clinical trial award – preproposal due may 23, 2022

investigators at or above the level of assistant professor (or equivalent) or

early-career investigator partnering principal investigator (pi) option:  investigators at or above the level of assistant professor (or equivalent) may collaborate on a single application with a young investigator (at the level of postdoctoral fellow up to early-career independent faculty) who meets the following criteria as of the application submission deadline date:

• ·      must be in a current postdoctoral training position or have completed postdoctoral training by the application deadline
• ·      is no more than 7 years from the receipt of a terminal degree
• ·      has the freedom to commit at least 50% time to the project
  • ·       supports research with the potential to have a major impact on the treatment and/or management of autism spectrum disorders (asd).
  • ·       preliminary data relevant to the proposed project are required.
• ·       early-career investigator partnering pi option supports the development of young investigators pursuing or wishing to pursue a career in asd clinical trial research.

pre-application is required; application submission is by invitation only.

• ·        the maximum period of performance is 4 years.
• ·        the maximum allowable funding for the entire period of performance is $1,800,000 in direct costs (plus indirect costs).
• ·        indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

early-career investigator partnering pi option:

• ·        the maximum period of performance is 4 years.
• ·        the maximum allowable funding for the entire period of performance is $2,100,000 for direct costs (plus indirect costs).
• ·        indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

idea development award – preproposal due may 23, 2022

investigators at or above the level of assistant professor (or equivalent)

multiple pi option: 
up to two investigators may collaborate on a single application, each of whom will be recognized as a principal investigator and receive a separate award. 

• ·      supports the development of innovative, high-impact ideas that advance the understanding of asd and ultimately lead to improved outcomes.
• ·      preliminary data relevant to the proposed project are required.
• ·     multiple pi option: up to two inestigators may collaborate ona single application, each of whom will be recognized as a pi and receive a separate award.
• ·     clinical trials or applications, including a clinical trial aim, are not allowed.
• ·     pre-application is required; application submission is by invitation only.
• ·      the maximum period of performance is 3 years.
• ·      the maximum allowable funding for the entire period of performance is $550,000 in direct costs (plus indirect costs).
• ·      for multiple pis, the combined funding for all pis for the entire period of performance may not exceed $550,000 in direct costs (plus indirect costs).
• ·      indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

career development award – preproposal due may 23, 2022

independent investigators at or below the level of assistant professor (or equivalent) or

established independent investigators in an area other than asd at or above the level of assistant professor (or equivalent) and seeking to transition to a career in asd, thereby bringing their expertise to the field

investigators must not have received a career development award (or equivalent) previously from any program within the congressionally directed medical research programs.

investigators must not have received more than $300,000 in total direct costs for previous or concurrent asd research as a pi of one or more federally or privately funded non-mentored, peer-reviewed grants.

investigators must hold a ph.d, m.d., m.d./ph.d, or equivalent at time of pre-application submission

• ·       supports early-career, independent investigators and/or the transition of established investigators from other research fields to conduct:

○       innovative, high-impact ideas or

○       early-phase, proof-of-principle clinical trials with the potential to have a major impact on asd

• ·       preliminary data relevant to the proposed project are required.

pre-application is required; application submission is by invitation only.

• ·        the maximum period of performance is 3 years.
• ·        the maximum allowable funding for the entire period of performance is $550,000 in direct costs (plus indirect costs).
• ·        indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final funding opportunity announcements available for downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrdc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the arp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org     

for more information, pleae contact jill sherman, international research facilitator, at intl.research@lakeheadu.ca.

following the recent statement by the honourable françois-philippe champagne, minister of innovation, science and industry, and the honourable jean-yves duclos, minister of health, and further to the commitment of the three federal granting agencies to support researchers and 世界杯2022赛程表淘汰赛 impacted by the crisis in ukraine the canadian institutes of health research (cihr), the natural sciences and engineering research council of canada (nserc) and the social sciences and humanities research council of canada (sshrc) have established a limited-time special response fund for trainees (ukraine), or srft-ukraine, to initiate or maintain the employment or financial support—via stipend or salary—of graduate 世界杯2022赛程表淘汰赛 and postdoctoral researchers who are directly impacted by the crisis in ukraine.

canada is recognized as a leader in building partnerships and uniting researchers and highly qualified personnel of different nationalities and cultures in the shared pursuit of scientific excellence. recognizing how the crisis in ukraine may affect the research landscape, this additional funding for grant holders will support trainees, defined as graduate 世界杯2022赛程表淘汰赛 or postdoctoral researchers, through salaries and stipends.

support can be requested for a period of up to 12 months. the maximum allowable amounts are as follows:

requested amounts must be pro-rated to reflect the expected duration of the support.

following the recent statement by the honourable françois-philippe champagne, minister of innovation, science and industry, and the honourable jean-yves duclos, minister of health and further to the commitment of the three federal granting agencies to support researchers and 世界杯2022赛程表淘汰赛 impacted by the crisis in ukraine the canadian institutes of health research (cihr), the natural sciences and engineering research council of canada (nserc), and the social sciences and humanities research council of canada (sshrc) have established a limited-time special response fund for trainees (ukraine), or srft-ukraine, to initiate or maintain the employment or financial support—via stipend or salary—of graduate 世界杯2022赛程表淘汰赛 and postdoctoral researchers who are directly impacted by the crisis in ukraine.  

canada is recognized as a leader in building partnerships and uniting researchers and highly qualified personnel of different nationalities and cultures in the shared pursuit of scientific excellence. recognizing how the crisis in ukraine may affect the research landscape, this additional funding for grant holders will support trainees, defined as graduate 世界杯2022赛程表淘汰赛 or postdoctoral researchers, through salaries and stipends.

support can be requested for a period of up to 12 months. the maximum allowable amounts are as follows:

requested amounts must be pro-rated to reflect the expected duration of the support.

following the recent statement by the honourable françois-philippe champagne, minister of innovation, science and industry, and the honourable jean-yves duclos, minister of health and further to the commitment of the three federal granting agencies to support researchers and 世界杯2022赛程表淘汰赛 impacted by the crisis in ukraine, the canadian institutes of health research (cihr), the natural sciences and engineering research council of canada (nserc), and the social sciences and humanities research council of canada (sshrc) have established a limited-time special response fund for trainees (ukraine), or srft-ukraine, to initiate or maintain the employment or financial support – via stipend or salary – of graduate 世界杯2022赛程表淘汰赛 and postdoctoral researchers, who are directly impacted by the crisis in ukraine. 

canada is recognized as a leader in building partnerships and uniting researchers and highly qualified personnel of different nationalities and cultures in the shared pursuit of scientific excellence. recognizing how the crisis in ukraine may affect the research landscape, this additional funding for grant holders will support trainees, defined as graduate 世界杯2022赛程表淘汰赛 or postdoctoral researchers through salaries and stipends.

support can be requested for a period of up to 12 months. the maximum allowable amounts are as follows:

requested amounts will be pro-rated to reflect the expected duration of the support.

if you are interested in submitting a proposal for a research hub, please contact the office of research (ahacquo1@lakeheadu.ca) no later than april 12, 2022.

through canada’s biomanufacturing and life sciences strategy (“the strategy”), the government of canada is investing more than $2.2 billion over seven years to continue growing a strong, competitive biomanufacturing and life sciences sector, and to ensure canada is prepared for future pandemics by increasing domestic capacity through investments and partnerships to produce life-saving vaccines and therapeutics. the strategy includes the following foundational investments to help build canada’s talent pipeline and research systems, as well as foster the growth of canadian life sciences firms:

• canada biomedical research fund (cbrf): an investment of $250 million to create a tri-agency program administered by the social sciences and humanities research council (sshrc) on behalf of the three federal research funding agencies (“the agencies”): sshrc, the canadian institutes of health research (cihr), and the natural sciences and engineering research council (nserc), to support high-risk, applied research, training and talent development partnership projects.
• biosciences research infrastructure fund (brif): an investment of $500 million for the canada foundation for innovation (cfi) to support the bioscience infrastructure needs of postsecondary institutions and research hospitals.
• clinical trials fund: a future investment of $250 million for cihr to support research teams and infrastructure across the country to conduct clinical trials that test vaccines and therapies, treatments and interventions to prevent, detect, treat or manage various diseases or medical conditions.

the cbrf and brif are based on an ecosystem approach, designed to build on existing assets and infrastructure, and to forge partnerships across multiple sectors, including industry and government research facilities. this is consistent with the holistic approach to investments under the strategy. to maximize impact and ensure investments complement and reinforce each other, the programs feature a two-stage, integrated competitive process:

• stage 1: selection of three to five research hubs
• stage 2: open, national call for partnered applied research, research-training, and infrastructure projects associated with the selected research hubs.

only research hub applications aligned with the strategy and proposing demonstrable contributions toward pandemic preparedness and the following goals will be considered for funding:

• increase specialized infrastructure, and capacity for multidisciplinary, applied research. address priority pandemic pathogens and emerging health threats through development of novel vaccines, therapeutics and diagnostics. focus on areas in which canadian research is cutting-edge, while addressing critical gaps that limit biomanufacturing.
• support training and development, to expand the pipeline of skilled research and talent. attract and develop highly qualified personnel, such as 世界杯2022赛程表淘汰赛 , postdoctoral researchers and early career researchers, across all disciplines; and technicians with industry-relevant skills and training in research, engineering and biomanufacturing, including good laboratory practice (glp) and good manufacturing practice (gmp) laboratories and facilities training.
• accelerate the translation of promising research into commercially viable products and processes. build on receptor capacity among public and private developers of vaccines, therapeutics and diagnostics; support the generation of intellectual property in canada; and increase the capacity of institutions to work collaboratively with companies, including those supported through the strategic innovation fund.

the aim is to improve pandemic readiness and sector growth by strengthening research and talent capacity in canada, and contributing to and leveraging collaborations across the entire biomanufacturing ecosystem and various sectors. the focus is pathogens with the greatest pandemic potential, especially respiratory and zoonotic diseases. priority pathogens include those identified by the world health organization, coalition for epidemic preparedness innovations, and the united states’ centers for disease control and prevention.

being ready for future pandemics requires targeting research, infrastructure and talent investments toward developing emerging vaccine, therapeutic and diagnostic technologies that can be produced at scale in canada, and that have the potential to address a range of pandemic pathogens (e.g., mrna, viral vector, protein subunit, small molecules, antivirals, monoclonal antibodies, immunomodulators).

this targeted investment strategy will provide companies in canada with a pipeline of relevant research and talent, as well as access to gmp-grade laboratories, through collaborations with postsecondary institutions and research hospitals. to further support pandemic readiness, the strategic innovation fund is investing in private sector drug development and biomanufacturing. research hubs are encouraged to consider these complementary investments, as applicable.

research hub applicants have flexibility to design their programs of research guided by the strategic objectives above, based on the potential hub’s collective strengths and existing areas of partnership with industry and government.

in stage 1, applications for research hubs must clearly indicate how the funding requested would support the research hub’s ability to significantly advance the strategy and the strategic objectives of the funding opportunity. potential hubs must also demonstrate how their collaborations would draw on key capabilities at institutions across canada, and on partnerships with government and industry.

in stage 2, research project applications and infrastructure requests associated with selected research hubs must demonstrate how the requested funds would contribute to the hub’s program of research, and significantly advance the strategy’s goals and the funding opportunity’s strategic objectives.

this scholar award recognizes outstanding physician-scientists whose work has potential to advance standard of care. each year up to 12 harrington scholar-innovators are chosen. the award includes:

• two-year grant
• $100,000 guaranteed, opportunity to qualify for up to $1,100,000
• drug development expertise and project management support
• a personalized team of drug developers and project manager for each award recipient
• expert business, commercialization and clinical development advice
• regulatory assistance
• intellectual property (ip) review and advice
• assistance identifying and securing additional financial support based on project needs

the harrington scholar-innovator award selection committee seeks breakthrough discoveries defined by innovation, creativity and potential for clinical impact, including:

• discoveries deemed to address unmet medical needs
• modulators of novel targets
• potential to be developed into a commercial program
• strong intellectual property (ip) or protection strategy
• may be a small molecule, biologic, or other therapeutic modality
• diagnostics or devices only acceptable as part of a therapeutic development project